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The	   DatScanTM	   and	   its	   SemiquanEﬁcaEon	   (SQ)	   can	  
provide	   advantages	   in	   the	   diagnosis	   of	   Parkinsonian	  
Syndromes	   (PS).	   To	   improve	   the	   SQ	   is	   recommended	  
the	   creaEon	   of	   adapted	   database	   (DB)	  with	   reference	  
values	  for	  the	  Nuclear	  Medicine	  Departments.	  1-­‐3	  
Previously	  to	  this	  work	  was	  created	  a	  adapted	  database	  
(DBRV)	  to	  Nuclear	  Medicine	  Department´s	  protocol	  and	  
populaEon	   of	   Infanta	   CrisEna´s	   Hospital	   located	   in	  
Badajoz,	   for	   paEents	   between	   the	   ages	   of	   60	   and	   75,	  
and	  reference	  values	  of	  the	  SQ	  were	  calculated	  (Table	  
1).	  	  
Aim:	   To	   evaluate	   the	   discriminaEon	   capacity	   of	   a	  
department´s	  adapted	  DB	  reference´s	  values	  of	  healthy	  
controls	  for	  DatScanTM.	  	  
IntroducBon	  
Subjects	  &	  Methods	  
Discussion/Conclusion	  
Binding	  RaBos	  (BR)	   Reference	  Value	  	  
A	   LeG	  Caudate	  Nucleus/Occipital	   2.60	  ±	  0.40	  
B	   Right	  Caudate	  Nucleus/Occipital	   2.57	  ±	  0.36	  
C	   LeG	  Putamen/Occipital	   2.29	  ±	  0.36	  
D	   	  Right	  Putamen/Occipital	   2.31	  ±	  0.35	  
E	   Striatum/Occipital	   2.44	  ±	  0.35	  
F	   LeG	  Striatum/Occipital	   2.44	  ±	  0.37	  
G	   Right	  Striatum/Occipital	   2.44	  ±	  0.34	  
H	   Putamen/Caudate	  Nucleus	   0.89	  ±	  0.07	  
Results	  
Figure	  1.	  Sum	  image	  of	  three	  transaxial	  slices	  where	  striatum	  is	  visible,	  with	  semiautomaEc	  
Regions	  of	  Interest	  (ROIs)	  on	  Caudate	  Nucleus	  (LeG	  and	  Right),	  Putamen	  (LeG	  and	  Right)	  and	  
Occipital	  	  	  	  	  
Table	  1.	  DBRV	  
It	  was	  used	  a	  semiautomaEc	  method	  for	  segmentaEon	  
and	  posterior	   calculi	   of	   binding	  potenEal	   in	   dopamine	  
transporters	   (DAT)	   in	   striatum	   structures	   and	   in	   a	  
nonspeciﬁc	   binding	   region	   (Figure	   1).	   All	   exams	   were	  
acquired	  by	  EANM´s	  Guidelines	  protocol	  and	  processed	  
3	   Emes	   for	   one	   operator	   and	   average	   values	   were	  
used3.	  For	  validaBon	  purpose	  of	   reference	  values	   two	  
diﬀerent	   DB	   with	   30	   paEents	   each,	   were	   considered:	  
DB	   of	   healthy	   controls	   (DBVGIIH)	   and	   DB	   of	   subjects	  
with	  PS	  (DBVGIIP),	  both	  were	  processed	  using	  the	  same	  
protocol	   and	   its	   results	  were	   compared	  with	   the	  ones	  
of	   DBRV.	   Receiver	   OperaEng	   CharacterisEc	   Curves	  
(ROCC)	  were	  calculated.	  	  	  	  	  
The	   BR	   C	   and	   D	  measures	   the	   uptake	   from	   putamen,	  
the	  ﬁrst	   and	  main	   structure	   to	  degenerate	   in	   subjects	  
with	  PS,	  so	  the	  AUC	  values	  (0.91	  and	  0.93)	  are	  excellent	  
measures	   to	  disEnguish	  between	  healthy	  paEents	  and	  
aﬀected	   ones.	   The	   BR	   A	   and	   B	   have	   the	   lower	   AUC	  
values	   (0.81	   and	   0.89)	   because	   they	   measures	   the	  
uptake	  from	  caudate	  nucleus	  which	  is	  the	  last	  structure	  
to	  degenerate	   in	  paEents	  with	  PS.	  The	   remaining	  AUC	  
values	   (0.88,	   0.86,	   0.87	   and	  0.87)	   of	   BR	   E,	   F,	  G	   and	  H	  
are	  good	  discriminatory	  measures.	  1-­‐2,4-­‐7	  
It´s	   possible	   to	   conclude	   that	   the	   DBRV	   and	   its	  
reference	   values	   newly	   created	   have	   good	  
discriminaEve	  capability	  between	  healthy	  controls	  and	  
subjects	   with	   PS.	   The	   new	   DB	   is	   an	   adapted	   and	  
improved	  tool	  for	  clinical	  use	  and	  assessment.	  	  
The	   Figures	   2-­‐9	   represents	   the	   ROCC	   of	   the	   Binding	  
RaEos	  (BR)	  A-­‐H,	  used	  for	  validaEon	  of	  DBRV.	  	  
By	  the	  ROCC	  assessment	  for	  each	  BR	  the	  values	  of	  Area	  
Under	  the	  Curve	  (AUC)	  were	  obtained:	  A	  (AUC=0.81),	  B	  
(AUC=0.79),	  C	  (AUC=0.91),	  D	  (AUC=0.93),	  E	  (AUC=0.88),	  
F	  (AUC=0.86),	  G	  (AUC=0.87),	  H	  (AUC=0.87).	  	  
Figure	  2.	  Curve	  ROC	  BR	  A	  	   Figure	  3.	  Curve	  ROC	  BR	  B	  	  
Figure	  4.	  Curve	  ROC	  BR	  C	  	   Figure	  5.	  Curve	  ROC	  BR	  D	  	  
Figure	  6.	  Curve	  ROC	  BR	  E	  	   Figure	  7.	  Curve	  ROC	  BR	  F	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